Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 21
Number of items: 21
  • Boekel, L., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies. The Lancet. Rheumatology, 4(6), e417-e429. https://doi.org/10.1016/S2665-9913(22)00102-3
  • Wieske, L., Tas, S. W., Takkenberg, R. B., Verstegen, N. J. M., Zwinderman, K. A. H., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study. The Lancet. Rheumatology, 4(5), e338-e350. https://doi.org/10.1016/S2665-9913(22)00034-0
  • Open Access
    van Kempen, Z. L. E., Wieske, L., Stalman, E. W., Kummer, L. Y. L., van Dam, P. J., Volkers, A. G., Boekel, L., Toorop, A. A., Strijbis, E. M. M., Tas, S. W., Wolbink, G. J., Löwenberg, M., van Sandt, C., ten Brinke, A., Verstegen, N. J. M., Steenhuis, M., Kuijpers, T. W., van Ham, S. M., Rispens, T., ... T2B! immunity against SARS-CoV-2 study group (2022). Longitudinal humoral response after SARS-CoV-2 vaccination in ocrelizumab treated MS patients: To wait and repopulate? Multiple sclerosis and related disorders, 57, Article 103416. https://doi.org/10.1016/j.msard.2021.103416
  • Open Access
    Wieske, L., Takkenberg, R. B., Tas, S. W., Bemelman, F. J., ten Brinke, A., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases. BMC Medicine, 20, Article 100. https://doi.org/10.1186/s12916-022-02310-7
  • Open Access
    Verstegen, N. J. M., Hagen, R. R., van den Dijssel, J., Kuijper, L. H., Kreher, C., Ashhurst, T., Kummer, L. Y. L., Steenhuis, M., Duurland, M., de Jongh, R., de Jong, N., van der Schoot, C. E., Bos, A. V., Mul, E., Kedzierska, K., van Dam, K. P. J., Stalman, E. W., Boekel, L., Wolbink, G., ... T2B! immunity against SARS-CoV-2 study group (2022). Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273. eLife, 11, Article e77969. https://doi.org/10.7554/eLife.77969
  • Open Access
    Palomares Cabeza, V., Kummer, L. Y. L., Wieske, L., Hagen, R. R., Duurland, M., Konijn, V. A. L., van Dam, K. P. J., Stalman, E. W., van de Sandt, C. E., Boekel, L., Verstegen, N. J. M., Steenhuis, M., Rispens, T., Tas, S. W., Wolbink, G., Killestein, J., Kuijpers, T. W., van Ham, S. M., Eftimov, F., ... Target-to-B! (T2B!) SARS-CoV-2 study group (2022). Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod. Neurology® Neuroimmunology & Neuroinflammation, 9(4), Article e1178. https://doi.org/10.1212/NXI.0000000000001178
  • Open Access
    Marsman, C., Verstegen, N. J. M., Streutker, M., Jorritsma, T., Boon, L., Ten Brinke, A., & van Ham, S. M. (2022). Termination of CD40L co-stimulation promotes human B cell differentiation into antibody-secreting cells. European journal of immunology, 52(10), 1662-1675. https://doi.org/10.1002/eji.202249972
  • Open Access
    van den Dijssel, J., Hagen, R. R., de Jongh, R., Steenhuis, M., Rispens, T., Geerdes, D. M., Mok, J. Y., Kragten, A. H. M., Duurland, M. C., Verstegen, N. J. M., van Ham, S. M., van Esch, W. J. E., van Gisbergen, K. P. J. M., Hombrink, P., ten Brinke, A., & van de Sandt, C. E. (2022). Parallel detection of SARS-CoV-2 epitopes reveals dynamic immunodominance profiles of CD8+ T memory cells in convalescent COVID-19 donors. Clinical & translational immunology, 11(10), Article e1423. https://doi.org/10.1002/cti2.1423
  • Open Access
    Verstegen, N. J. M., Ubels, V., Westerhoff, H. V., van Ham, S. M., & Barberis, M. (2021). System-Level Scenarios for the Elucidation of T Cell-Mediated Germinal Center B Cell Differentiation. Frontiers in Immunology, 12, Article 734282. https://doi.org/10.3389/fimmu.2021.734282
  • Open Access
    Unger, P.-P. A., Verstegen, N. J. M., Marsman, C., Jorritsma, T., Rispens, T., ten Brinke, A., & van Ham, S. M. (2021). Minimalistic In Vitro Culture to Drive Human Naive B Cell Differentiation into Antibody-Secreting Cells. Cells, 10(5), Article 1183. https://doi.org/10.3390/cells10051183
Page 2 of 3